COMPASS Pathways Plc (CMPS)

Name: COMPASS Pathways Plc (CMPS) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: COMPASS Pathways Plc (CMPS)

Stock Card

$13.73

$-0.91 (-6.22%)

As on 28-Aug-2026 16:28EDT

Market cap

$1,901 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

Div. Yield

0 %

COMPASS Pathways (CMPS) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 13.69 High: 14.71

52 Week Range

Low: 4.40 High: 15.40

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-3.2 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-3.5
Debt to Equity

0.6
Book Value

$0.6
EPS

$-4.2
Face value

--
Shares outstanding

138,476,822

6 Years Aggregate

CFO

$-339.94 Mln

EBITDA

$-373.92 Mln

Net Profit

$-375.34 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
COMPASS Pathways (CMPS)	99.0	21.8	15.9	190.9	15.2	-15.5	--
BSE Sensex	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021
COMPASS Pathways (CMPS)	82.5	-56.5	9.0	-63.7	-53.6
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3
BSE Sensex	9.1	8.1	18.7	4.4	22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
COMPASS Pathways (CMPS)	13.7	1,901.3	0.0	-394.2	--	--	--	24.0
Arrowhead Pharmaceuticals (ARWR)	84.9	11,993.9	669.5	-320.0	-0.8	-71.1	--	26.9
Cytokinetics Inc (CYTK)	72.1	10,022.2	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	54.5	13,491.7	2,435.9	860.6	31.0	43	17.4	7.4
Halozyme Therapeutics (HALO)	105.4	11,957.0	1,663.7	413.6	36.3	430	30.9	84.5
Krystal Biotech (KRYS)	351.5	10,402.8	440.5	241.5	33.4	18.7	44.1	7.8
Madrigal Pharmaceuticals (MDGL)	533.8	12,332.1	1,283.9	-325.1	-19.0	-57.7	--	24.0
Medpace Holdings (MEDP)	600.7	16,765.1	2,782.3	491.5	21.1	110.1	35.2	39.3
Praxis Precision MedicinesÂ Inc (PRAX)	344.8	9,625.4	0.0	-339.1	--	-30.6	--	7.6
Protagonist Therapeutics (PTGX)	144.3	9,339.4	282.0	82.9	-28.6	11.4	140.1	11.5

Shareholding Pattern

View Details

About COMPASS Pathways (CMPS)

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of... treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom. Read more

CEO & Director

Mr. Kabir Nath M.A., M.B.A.
CEO & Director

Mr. Kabir Kumar Nath M.A., M.B.A.
Headquarters

London
Website

https://compasspathways.com

FAQs for COMPASS Pathways (CMPS)

What is the current share price of COMPASS Pathways Plc (CMPS) Today?

The share price of COMPASS Pathways Plc (CMPS) is $13.73 (NASDAQ) as of 28-Aug-2026 16:28 EDT. COMPASS Pathways Plc (CMPS) has given a return of 15.25% in the last 3 years.

What is the current PB & PE ratio of COMPASS Pathways Plc (CMPS)?

Since, TTM earnings of COMPASS Pathways Plc (CMPS) is negative, P/E ratio is not available.
The P/B ratio of COMPASS Pathways Plc (CMPS) is 23.99 times as on 28-Aug-2026, a 348 premium to its peers’ median range of 5.35 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-2.24	-12.23
2024	-1.67	1.67
2023	-4.58	2.40
2022	-3.72	1.88
2021	-12.89	3.25

What is the 52 Week High and Low of COMPASS Pathways Plc (CMPS)?

The 52-week high and low of COMPASS Pathways Plc (CMPS) are Rs 15.40 and Rs 4.40 as of 30-Aug-2026.

What is the market cap of COMPASS Pathways Plc (CMPS)?

COMPASS Pathways Plc (CMPS) has a market capitalisation of $ 1,901 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in COMPASS Pathways Plc (CMPS)?

Before investing in COMPASS Pathways Plc (CMPS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.